(Q71655509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7525125%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Endocrine profiles during administration of the new non-steroidal anti-androgen Casodex in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7525125%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Endocrine profiles during administration of the new non‐steroidal anti‐androgen Casodex in prostate cancer (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

18 May 2024

1 reference

J. Verhelst

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

L. Denis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

P. Van Vliet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

H. Van Poppel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

J. Braeckman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

P. Van Cangh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

J. Mattelaer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

D. D'Hulster

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

C. Mahler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525125

18 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7525125

18 May 2024

publication date

1 October 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7525125%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1994.tb02585.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2265.1994.tb02585.x

18 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

18 May 2024

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7525125%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7525125%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7525125%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

525-530

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7525125%20AND%20SRC:MED&resulttype=core&format=json

The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing

20 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

BIOLOGICAL ACTIVITY OF ANTIANDROGENS

18 May 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334).

18 May 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

Casodex: preclinical studies

18 May 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

Ocular toxicity of Anandron in patients treated for prostatic cancer

18 May 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

The effect of flutamide on testosterone metabolism and the plasma levels of androgens and gonadotropins

18 May 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study

18 May 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

Clinical profile of a new non-steroidal antiandrogen.

18 May 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

Pharmacological and clinical studies of the antiandrogen Anandron

18 May 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

Effect of Casodex on sleep-related erections in patients with advanced prostate cancer

18 May 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

The Response of Advanced Prostatic Cancer to a New Non-Steroidal Antiandrogen: Results of a Multicenter Open Phase II Study of Casodex

18 May 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

Secretion of unconjugated androgens and estrogens by the normal and abnormal human testis before and after human chorionic gonadotropin

18 May 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

Effect of Flutamide on Estradiol Metabolism*

18 May 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1994.TB02585.X

18 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7525125%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference